Evaluation of cochlear functions in infants exposed to SARS-CoV-2 intrauterine

dc.authoridÇELİK, TURGUT/0000-0003-3811-476X
dc.authoridKoca, cigdem fırat/0000-0001-8990-0651
dc.authoridşimşek, agit/0000-0003-1572-1188
dc.authoridAydin, Sukru/0000-0003-1105-3338
dc.authorwosidÇELİK, TURGUT/AAS-4089-2021
dc.authorwosidKoca, cigdem fırat/ABK-7472-2022
dc.authorwosidşimşek, agit/AEG-5698-2022
dc.authorwosidYaşar, Şeyma/ABI-8055-2020
dc.authorwosidAydin, Sukru/AAM-3613-2021
dc.contributor.authorCelik, Turgut
dc.contributor.authorSimsek, Agit
dc.contributor.authorKoca, Cigdem Firat
dc.contributor.authorAydin, Sukru
dc.contributor.authorYasar, Seyma
dc.date.accessioned2024-08-04T20:49:18Z
dc.date.available2024-08-04T20:49:18Z
dc.date.issued2021
dc.departmentİnönü Üniversitesien_US
dc.description.abstractPurpose: The novel coronavirus (SARS-CoV-2) caused an acute respiratory illness named COVID-19 and the disease spread all over the World. Fever, cough, fatigue, gastrointestinal infection symptoms form the main clinical symptoms. Pregnants and newborns form a vulnerable population and urgent measures must be addressed. Studies about the effect of COVID-19 on pregnant women, developing fetuses, and infants are limited. Various viral diseases can cause congenital or acquired, unilateral or bilateral hearing loss. Methods: 37 infants whose mother was pregnant between March 2020 and December 2020 and were born after the diagnosis of COVID- 19 during pregnancy and 36 healthy infants were included in the study. Transient evoked otoacoustic emission (TEOAE), distortion product otoacoustic emission (DPOAE) and contralateral suppression of OAE (CLS OAE) tests were performed on all infants. Results: According to the TEOAE results of patients and controls in the silent a statistically significant difference was observed between the two groups at 3 kHz and 4 kHz (p < 0.05). Contralateral suppression of OAE test results of patients and controls a statistically significant difference was found in all frequencies (p< 0.05). Suppression was much more effective at all frequencies in the normal group than patient group. This difference was found to be more significant at higher frequencies (2,3 and 4 kHz) (p < 0.001). Conclusions: Our results suggest an insufficiency in medial olivocochlear efferent system in infants exposed to SARS-CoV-2 intrauterine. Cochlear functions should be examined in infants whose mothers had COVID-19.en_US
dc.identifier.doi10.1016/j.amjoto.2021.102982
dc.identifier.issn0196-0709
dc.identifier.issn1532-818X
dc.identifier.issue4en_US
dc.identifier.pmid33621767en_US
dc.identifier.scopus2-s2.0-85101282033en_US
dc.identifier.scopusqualityQ1en_US
dc.identifier.urihttps://doi.org/10.1016/j.amjoto.2021.102982
dc.identifier.urihttps://hdl.handle.net/11616/99777
dc.identifier.volume42en_US
dc.identifier.wosWOS:000670064700001en_US
dc.identifier.wosqualityQ2en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherW B Saunders Co-Elsevier Incen_US
dc.relation.ispartofAmerican Journal of Otolaryngologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectSARS-CoV-2en_US
dc.subjectInfantsen_US
dc.subjectPregnancyen_US
dc.subjectCochlear functionsen_US
dc.titleEvaluation of cochlear functions in infants exposed to SARS-CoV-2 intrauterineen_US
dc.typeArticleen_US

Dosyalar